I

ICH Study Center GmbH & Co. KG | Hamburg, Germany

Research site
(Unclaimed)
Location
Grindelallee 35, Hamburg, Hamburg, Germany

Site insights

Top conditions

Top treatments

JNJ-56136379
Bictegravir
Lenacapavir
JNJ-73763989
TAF
GS-6207
Entecavir
TDF
Tenofovir disoproxil fumarate
Tenofovir alafenamide

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 9 total trials

DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053)

This is a randomized, active-controlled, double-blind clinical study designed to evaluate the antiretroviral activity, safety, and tolerability of do...

Enrolling
HIV-1 Infection
Drug: BIC/FTC/TAF
Drug: Placebo to DOR/ISL

The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC) plus lenacapavir (LEN), versus...

Enrolling
HIV-1-infection
Drug: Stable Baseline Regimen
Drug: Bictegravir

The primary objective of this study is to evaluate the antiviral activity of lenacapavir (formerly GS-6207) administered as an add-on to a failing re...

Active, not recruiting
HIV-1-infection
Drug: Optimized Background Regimen (OBR)
Drug: Failing ARV Regimen

The main purpose of this study is to compare two different types of HIV treatments, in terms of effectiveness and improvement of side effects, for pa...

Active, not recruiting
HIV/AIDS
Drug: Biktarvy
Drug: Symtuza

Trial sponsors

Gilead Sciences logo
J
H
Merck Sharp & Dohme (MSD) logo
N
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems